Dec 28, 2012, 08.26 AM IST | Source: PTI

Aurobindo Pharma gets USFDA nod for Nafcillin injections

Drug firm Aurobindo Pharma said it has received final approval by the US health regulator to manufacture and market Nafcillin for injection used for treating bacterial infections in the American market.

Drug firm Aurobindo Pharma said it has received final approval by the US health regulator to manufacture and market Nafcillin for injection used for treating bacterial infections in the American market. The company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Nafcillin for injection USP, packaged in 1g and 2g vials and Nafcillin for injection USP 10g/vial pharmacy bulk package, Aurobindo Pharma said in a statement.

Also Read: Plan panel sets $100 bn target for pharma sector by 2020

"The products are ready for launch," it added. These abbreviated new drug applications (ANDAs) have been approved out of the company's unit XII formulation facility in Hyderabad and will be marketed and sold by its US subsidiary AuroMedics Pharma LLC, Aurobindo Pharma said. The company currently has a total of 171 ANDA approvals (145 final approvals including 2 from Aurolife Pharma LLC and 26 tentative approvals), it added.

"Nafcillin for injection is indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug," the company said. Shares of Aurobindo Pharma were trading at Rs 192.40 per scrip on BSE, down 0.31 per cent from its previous close.

Aurobindo Pharm stock price

On April 17, 2014, Aurobindo Pharma closed at Rs 551.35, up Rs 3.35, or 0.61 percent. The 52-week high of the share was Rs 575.95 and the 52-week low was Rs 138.45.


The company's trailing 12-month (TTM) EPS was at Rs 31.05 per share as per the quarter ended December 2013. The stock's price-to-earnings (P/E) ratio was 17.76. The latest book value of the company is Rs 100.84 per share. At current value, the price-to-book value of the company is 5.47.

Set email alert for

ADS BY GOOGLE

Buy & sell politicians on Power Play
- the political stock exchange

Price Update

Arvind Kejriwal

1702.68 -2.87 -0.17%

15568

Bought today

23782

Sold today

0.11%

User holding

video of the day

Chandra says satisfied with TCS' FY14, FY15 to be better

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.